In the last 12 months, insiders at AVENUE THERAPEUTICS, INC. ($ATXI) filed 30 transactions with the SEC: 4 open-market purchases totaling $553,551 and 8 sales totaling $86,743. Net insider sentiment: net buying.
AVENUE THERAPEUTICS, INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Fortress Biotech, Inc. (TenPercentOwner) — 4 transactions totaling $301,255
- ROSENWALD LINDSAY A MD (Director) — 3 transactions totaling $251,046
- Davidow Robert L (TenPercentOwner) — 6 transactions totaling $86,560
- KRANZLER JAY D (Director) — 5 transactions totaling $1,386
- Herskowitz Neil (Director) — 3 transactions totaling $46
View all SEC Filings for AVENUE THERAPEUTICS, INC. (ATXI).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2025 | Fortress Biotech, Inc. | Not found | A | COMMON STOCK, PAR VALUE $0.0001 | 33724 | $0.00 | 328,524.0000 | 2,108,670 | 11.44% | 1.60% |
| Dec. 2, 2024 | Herskowitz Neil | Director | S | COMMON STOCK, PAR VALUE $0.0001 | 23 | $2.00 | 97.0000 | 341,324 | 19.17% | 0.01% |
| Nov. 5, 2024 | KRANZLER JAY D | Director | S | COMMON STOCK, PAR VALUE $0.0001 | 61 | $2.24 | 559.0000 | 341,324 | 9.84% | 0.02% |
| Sept. 27, 2024 | KRANZLER JAY D | Director | P | COMMON STOCK, PAR VALUE $0.0001 | 3 | $2.40 | 123.0000 | 341,324 | 2.50% | 0.00% |
| Sept. 30, 2024 | KRANZLER JAY D | Director | P | COMMON STOCK, PAR VALUE $0.0001 | 497 | $2.50 | 620.0000 | 341,324 | 404.07% | 0.15% |
| Sept. 23, 2024 | ROSENWALD LINDSAY A MD | Director | A | Employee stock option (right to buy) | 30000 | $0.00 | 30,000.0000 | 341,324 | 9999.99% | 8.79% |
| Sept. 23, 2024 | Herskowitz Neil | Director | A | Employee stock option (right to buy) | 30000 | $0.00 | 30,000.0000 | 341,324 | 9999.99% | 8.79% |
| Sept. 23, 2024 | Oltmans Curtis Gale | Director | A | Employee stock option (right to buy) | 30000 | $0.00 | 30,000.0000 | 341,324 | 9999.99% | 8.79% |
| Sept. 23, 2024 | MacLean Alexandra | Chief Executive Officer | A | COMMON STOCK, PAR VALUE $0.0001 | 170000 | $0.00 | 170,000.0000 | 341,324 | 9999.99% | 49.81% |
| Sept. 23, 2024 | KRANZLER JAY D | Director | A | Employee stock option (right to buy) | 30000 | $0.00 | 30,000.0000 | 341,324 | 9999.99% | 8.79% |
| Sept. 23, 2024 | Jin David | Interim PFO and COO | A | COMMON STOCK, PAR VALUE $0.0001 | 65000 | $0.00 | 65,000.0000 | 341,324 | 9999.99% | 19.04% |
| Sept. 23, 2024 | Charles Faith L. | Director | A | Employee stock option (right to buy) | 30000 | $0.00 | 30,000.0000 | 341,324 | 9999.99% | 8.79% |
| Dec. 11, 2023 | Davidow Robert L | TenPercentOwner | S | Common Stock | 264000 | $0.14 | 1,219,800.0000 | 0 | 17.79% | 0.00% |
| Dec. 11, 2023 | Davidow Robert L | TenPercentOwner | S | Common Stock | 18000 | $0.15 | 1,219,800.0000 | 0 | 1.45% | 0.00% |
| Dec. 11, 2023 | Davidow Robert L | TenPercentOwner | S | Common Stock | 61000 | $0.14 | 1,219,800.0000 | 0 | 4.76% | 0.00% |
| Dec. 11, 2023 | Davidow Robert L | TenPercentOwner | S | Common Stock | 126000 | $0.14 | 1,219,800.0000 | 0 | 9.36% | 0.00% |
| Dec. 11, 2023 | Davidow Robert L | TenPercentOwner | S | Common Stock | 128000 | $0.14 | 1,219,800.0000 | 0 | 9.50% | 0.00% |
| Dec. 11, 2023 | Davidow Robert L | TenPercentOwner | S | Common Stock | 20000 | $0.14 | 1,219,800.0000 | 0 | 1.61% | 0.00% |
| Sept. 8, 2023 | ROSENWALD LINDSAY A MD | Director | P | Common Stock | 348675 | $0.72 | 354,318.0000 | 0 | 6178.89% | 0.00% |
| Sept. 8, 2023 | Fortress Biotech, Inc. | TenPercentOwner | P | Common Stock | 418410 | $0.72 | 1,032,390.0000 | 0 | 68.15% | 0.00% |
| June 30, 2023 | Charles Faith L. | Director | A | Employee stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | Jin David | Interim PFO and COO | A | Employee stock option (right to buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | ROSENWALD LINDSAY A MD | Director | A | Employee stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | KRANZLER JAY D | Director | A | Employee stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | Oltmans Curtis Gale | Director | A | Employee stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | Herskowitz Neil | Director | A | Employee stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| June 29, 2023 | MacLean Alexandra | Chief Executive Officer | A | Employee stock option (right to buy) | 800000 | $0.00 | 800,000.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2023 | Fortress Biotech, Inc. | TenPercentOwner | A | COMMON STOCK, PAR VALUE $0.0001 | 52419 | $0.00 | 613,980.0000 | 0 | 9.33% | 0.00% |
| Dec. 31, 2022 | Fortress Biotech, Inc. | TenPercentOwner | A | COMMON STOCK, PAR VALUE $0.0001 | 90909 | $0.00 | 330,245.0000 | 0 | 37.98% | 0.00% |
| Jan. 3, 2023 | Fortress Biotech, Inc. | TenPercentOwner | A | COMMON STOCK, PAR VALUE $0.0001 | 231316 | $0.00 | 561,561.0000 | 0 | 70.04% | 0.00% |